Novel Immunotherapies in Relapsed/Refractory Multiple Myeloma: What Does the Future Hold?

Join Drs Leleu, Krishnan, and Rodriquez Otero discussing the immunotherapy highlights presented at the summer conferences. Credit available for this activity expires: 8/2/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/955670?src=mkm_podcast_addon_955670